Current challenges in the management of children with idiopathic thrombocytopenic purpura

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Much progress has been made during the past several decades in the diagnosis and management of childhood idiopathic thrombocytopenic purpura (ITP). Although we do not yet know ITP's cause, opportunities for research discovery in other areas have blossomed in recent years. One major step forward has been realization that outcomes other than platelet count are important in children with ITP, most especially the severity of hemorrhage, cost and side effects of treatment, and overall quality of life. The classical definition of chronic ITP (thrombocytopenia lasting greater than 6 months) has been questioned. Debate continues whether ITP can truly be cured, especially when it lasts for years. Much excitement has recently been generated as a result of a new mechanism of ITP treatment, that is, enhancing platelet production. Yet problems continue regarding how best to conduct research involving newly diagnosed ITP patients, for a number of barriers are still to be overcome. Fortunately, however, abundant information and support for ITP patients and their families is now much more available than in years past.

Original languageEnglish (US)
Pages (from-to)681-684
Number of pages4
JournalPediatric Blood and Cancer
Volume47
Issue number5 SUPPL.
DOIs
StatePublished - Oct 15 2006

Fingerprint

Idiopathic Thrombocytopenic Purpura
Inosine Triphosphate
Platelet Count
Research
Thrombocytopenia
Blood Platelets
Quality of Life
Hemorrhage
Costs and Cost Analysis
Therapeutics

Keywords

  • ITP
  • Platelet
  • Thrombocytopenia

ASJC Scopus subject areas

  • Cancer Research
  • Pediatrics, Perinatology, and Child Health
  • Hematology

Cite this

Current challenges in the management of children with idiopathic thrombocytopenic purpura. / Buchanan, George R.; Adix, Leah.

In: Pediatric Blood and Cancer, Vol. 47, No. 5 SUPPL., 15.10.2006, p. 681-684.

Research output: Contribution to journalArticle

@article{f1cb69cbc83542e1bf7df0c536595561,
title = "Current challenges in the management of children with idiopathic thrombocytopenic purpura",
abstract = "Much progress has been made during the past several decades in the diagnosis and management of childhood idiopathic thrombocytopenic purpura (ITP). Although we do not yet know ITP's cause, opportunities for research discovery in other areas have blossomed in recent years. One major step forward has been realization that outcomes other than platelet count are important in children with ITP, most especially the severity of hemorrhage, cost and side effects of treatment, and overall quality of life. The classical definition of chronic ITP (thrombocytopenia lasting greater than 6 months) has been questioned. Debate continues whether ITP can truly be cured, especially when it lasts for years. Much excitement has recently been generated as a result of a new mechanism of ITP treatment, that is, enhancing platelet production. Yet problems continue regarding how best to conduct research involving newly diagnosed ITP patients, for a number of barriers are still to be overcome. Fortunately, however, abundant information and support for ITP patients and their families is now much more available than in years past.",
keywords = "ITP, Platelet, Thrombocytopenia",
author = "Buchanan, {George R.} and Leah Adix",
year = "2006",
month = "10",
day = "15",
doi = "10.1002/pbc.20968",
language = "English (US)",
volume = "47",
pages = "681--684",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "5 SUPPL.",

}

TY - JOUR

T1 - Current challenges in the management of children with idiopathic thrombocytopenic purpura

AU - Buchanan, George R.

AU - Adix, Leah

PY - 2006/10/15

Y1 - 2006/10/15

N2 - Much progress has been made during the past several decades in the diagnosis and management of childhood idiopathic thrombocytopenic purpura (ITP). Although we do not yet know ITP's cause, opportunities for research discovery in other areas have blossomed in recent years. One major step forward has been realization that outcomes other than platelet count are important in children with ITP, most especially the severity of hemorrhage, cost and side effects of treatment, and overall quality of life. The classical definition of chronic ITP (thrombocytopenia lasting greater than 6 months) has been questioned. Debate continues whether ITP can truly be cured, especially when it lasts for years. Much excitement has recently been generated as a result of a new mechanism of ITP treatment, that is, enhancing platelet production. Yet problems continue regarding how best to conduct research involving newly diagnosed ITP patients, for a number of barriers are still to be overcome. Fortunately, however, abundant information and support for ITP patients and their families is now much more available than in years past.

AB - Much progress has been made during the past several decades in the diagnosis and management of childhood idiopathic thrombocytopenic purpura (ITP). Although we do not yet know ITP's cause, opportunities for research discovery in other areas have blossomed in recent years. One major step forward has been realization that outcomes other than platelet count are important in children with ITP, most especially the severity of hemorrhage, cost and side effects of treatment, and overall quality of life. The classical definition of chronic ITP (thrombocytopenia lasting greater than 6 months) has been questioned. Debate continues whether ITP can truly be cured, especially when it lasts for years. Much excitement has recently been generated as a result of a new mechanism of ITP treatment, that is, enhancing platelet production. Yet problems continue regarding how best to conduct research involving newly diagnosed ITP patients, for a number of barriers are still to be overcome. Fortunately, however, abundant information and support for ITP patients and their families is now much more available than in years past.

KW - ITP

KW - Platelet

KW - Thrombocytopenia

UR - http://www.scopus.com/inward/record.url?scp=33748485816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748485816&partnerID=8YFLogxK

U2 - 10.1002/pbc.20968

DO - 10.1002/pbc.20968

M3 - Article

C2 - 16933253

AN - SCOPUS:33748485816

VL - 47

SP - 681

EP - 684

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 5 SUPPL.

ER -